Vor Biopharma VOR
$19.19 +$0.67 (+3.62%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $19.20 +0.05%
Open$18.14
Prev close$18.52
Day range$17.99 – $19.93
Volume1.56M
Market cap$1.18B
P/E (TTM)0.1
Dividend yield–
VOR Stock News
Headlines matching Vor Biopharma or the VOR ticker, most recent first.
- Jefferies Maintains Vor Biopharma(VOR.US) With Buy Rating, Cuts Target Price to $48 Negative
- Stifel Maintains Vor Biopharma(VOR.US) With Buy Rating, Maintains Target Price $40
- Citi Maintains Vor Biopharma(VOR.US) With Buy Rating, Maintains Target Price $50
- Wells Fargo Maintains Vor Biopharma(VOR.US) With Buy Rating, Maintains Target Price $30
- Vor Biopharma | 4: Statement of changes in beneficial ownership of securities-10% Owner RA CAPITAL MANAGEMENT, L.P.
- Wedbush Maintains Vor Biopharma(VOR.US) With Hold Rating, Raises Target Price to $27 Positive
- H.C. Wainwright Maintains Vor Biopharma(VOR.US) With Buy Rating, Maintains Target Price $31
- Vor Biopharma | 4: Statement of changes in beneficial ownership of securities-10% Owner RA CAPITAL MANAGEMENT, L.P.
- Vor Biopharma | 4: Statement of changes in beneficial ownership of securities-Director RA CAPITAL MANAGEMENT, L.P.
- HC Wainwright & Co. Reiterates Buy on Vor Biopharma, Maintains $31 Price Target
- Vor Biopharma Price Target Maintained With a $31.00/Share by HC Wainwright & Co.
- TD Cowen Maintains Vor Biopharma(VOR.US) With Buy Rating
- Wedbush Maintains Vor Biopharma(VOR.US) With Hold Rating, Raises Target Price to $18 Positive
- Vor Biopharma | 4: Statement of changes in beneficial ownership of securities-Director RA CAPITAL MANAGEMENT, L.P.
- Vor Biopharma | 4: Statement of changes in beneficial ownership of securities-Director RA CAPITAL MANAGEMENT, L.P.
No comments yet — be the first to weigh in on VOR.
Sign in to join the discussion.